Skip to main content

Bone Void Fillers Market Size to Surpass USD 5.02 Billion by 2030, exhibiting a CAGR of 6.3%

As per the report by Fortune Business Insights, the global Bone Void Fillers Market size is projected to reach USD 5.02 Billion by 2030, at a CAGR of 6.3% during the forecast period.

Pune, India, June 05, 2023 (GLOBE NEWSWIRE) — The global bone void fillers market size was USD 3.09 billion in 2022. The market is predicted to rise from USD 3.27 billion in 2023 to reach USD 5.02 billion by 2030, exhibiting a CAGR of 6.3% during the projected period. The surge is due to the growing prevalence of numerous bone diseases such as bone infections and bone tumors. Fortune Business InsightsTM has presented this information in its report titled, “Bone Void Fillers Market, 2023-2030”.

Key Industry Developments:

January 2022: BONESUPPORT AB announced a distribution agreement with OrthoPediatrics Corp. to distribute CERAMENT BONE VOID FILLER (BVF) to pediatric hospitals within the U.S.


Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/bone-void-fillers-market-101015


Key Takeaways:

  • Trauma surgeries dropped by 21.2% to 66.7%, elective orthopaedic surgeries by 33.3% to 100%, and patient visits for these procedures dropped by 37.7% to 74.2%.
  • The U.S. FDA granted the business permission to deploy its antibiotic eluting void filler solution in its first clinical trial.
  • According to the American Cancer Society, Inc., 3,910 primary bone cancer cases are likely to be diagnosed in the year 2022, which is expected to drive product demand over the anticipated period.
  • The U.S. Food and Drug Administration (FDA) has given BONESUPPORT AB permission to use CERAMENT BVF as a bone void filler.

Discover the Leading Players Featured in the Report:
BONESUPPORT AB (Sweden), Biocomposites (U.K.), Collagen Matrix, Inc (U.S.), Zimmer Biomet (U.S.), Stryker (U.S.), Arthrex, Inc. (U.S.), DePuy Synthes (U.S.), Graftys (France)

Report Scope & Segmentation

Report CoverageDetails
Forecast Period2023 to 2030
Forecast Period 2023 to 2030 CAGR6.3 %
2030 Value ProjectionUSD 5.02 Billion
Base Year2022
Bone Void Fillers Market Size in 2023USD 3.27 billion
Historical Data for2019 to 2021
No. of Pages140


Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/bone-void-fillers-market-101015


Drivers & Restraints:

Market Growth to be Driven by Increase in Bone Diseases and Other Related Incidents

The rising prevalence of bone-related diseases, such as bone tumors and osteomyelitis, is propelling the market growth. In addition, other types of bone lesions, trauma, and bone fractures necessitate the use of bone void fillers. The American Cancer Society predicted 3,910 primary bone cancer diagnoses in 2022, which is expected to fuel the market for bone void fillers over the forecast period.

However, growing clinical limitations and under penetration of bone void filling materials led to a reduction in their adoption. This factor may limit the bone void fillers market growth.

Regional Insights:

North America to Account for the Largest Market Share due to Adoption of Synthetic Void Fillers

North America dominated the bone void fillers market share in 2022 and is expected to maintain its dominance over the forecast period. The rapid adoption of synthetic void fillers involving various material types, such as tricalcium phosphate and calcium sulfate, and the increased launch of advanced products by market players, are expected to drive the market growth in the region.

Europe held the second-largest market share in 2022 and is expected to grow at a significant CAGR during the forecast period. The growth is attributable to the presence of strong and emerging market players such as Biocomposites and BONESUPPORT AB.


Quick Buy – Bone Void Fillers Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101015


Segments:

Demineralized Bone Matrix Segment to Dominate Driven by Growing Product Adoption

On the basis of type, the market is divided into demineralized bone matrix, collagen matrix, calcium sulfate, tri-calcium phosphate, and others. The demineralized bone matrix segment is set to dominate over the estimated period. The surge is on account of the robust DBM presence in the portfolio of various companies.

Putty Segment to Record Substantial Demand Impelled by Rising Product Launches

On the basis of form, the market is segmented into gel, granules, paste, putty, and others. The putty segment held the highest market share in 2022 and is estimated to grow at the highest CAGR over the study period. The rise is propelled by the surging prevalence of bone diseases in developing countries.

Hospitals Segment to Register Lucrative Demand Propelled by the Rising Number of Orthopedic Surgeries

By end-user, the market is fragmented into hospital, specialty clinics, and others. The hospitals segment is anticipated to dominate due to increasing number of hospitals in developing and developed countries.

Geographically, the market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Report Coverage:

The report focuses on key elements such as market product launches. It also includes an overview of bone void filler guidelines, indication, site of placement of bone void filling material, and key industry developments such as partnerships, mergers, and acquisitions.

Competitive Landscape:

Zimmer Biomet, Stryker, and DePuy Synthes are market leaders with sizable market shares in 2021. The majority of bone void fillers are manufactured by companies with a strong product portfolio that targets the spine, which is the most common application area. These companies are also expected to strengthen their position in the market through the introduction of new products and acquisitions of other companies.

FAQ’s

How big is the Bone Void Fillers Market?

Bone Void Fillers Market size was USD 3.27 Billion in 2023.

How fast is the Bone Void Fillers Market growing?

The Bone Void Fillers Market will exhibit a CAGR of 6.3% during the forecast period, 2023-2030

Related Reports:

Demineralized Bone Matrix (DBM) Market Share, Size, Trends and Forecast 2023-2026

Bone Graft Substitutes Market Size, Share, Trends, Growth | Global Forecast Report 2026

Orthobiologics Market Size, Share, Trends, Growth 2023-2026

U.S. Bone Void Fillers Market Trends, Growth 2023-2027

About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.